About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 243 record(s)
Req # A-2020-18442
A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was…Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18732
A detailed summary of the PMPRB's use of the excessive price penalty on pharmaceutical companies from June 1, 2019 to November 26, 2020. For each penalty, break it down by date, company charged, drug in question, and fine levied.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # ATIP #5 - 2020-2021
Total amount spent on advertising on a month to month basis (separating for production and media placement costs) from budget year 2019-2020 to September 9, 2020Organization: Canada Deposit Insurance Corporation
October 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back…Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2019-0008
Please provide all quarterly portfolio updates for the SD Tech Fund in fiscal years 2019 and 2020. Please provide the records digitally (via email or Canada Post epost if possible). Please provide any and all communications, including but not…Organization: Sustainable Development Technology Canada
March 2020
Req # A-2019-2020-013
Please provide information on the gender breakdown of permanent employees at the Office of the Commissioner of Lobbying for the fiscal years 2010-2018.Organization: Office of the Commissioner of Lobbying of Canada
February 2020